Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Comparison of Clinicopathologic Features and Survival of Histopathologically Amelanotic and Pigmented Melanomas: A Population-Based Study.

Thomas NE, Kricker A, Waxweiler WT, Dillon PM, Busam KJ, From L, Groben PA, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Orlow I, Paine S, Ollila DW, Reiner AS, Luo L, Hao H, Frank JS, Begg CB, Berwick M; for the Genes, Environment, and Melanoma (GEM) Study Group.

JAMA Dermatol. 2014 Aug 27. doi: 10.1001/jamadermatol.2014.1348. [Epub ahead of print]

PMID:
25162299
[PubMed - as supplied by publisher]
2.

Sun Exposure and Melanoma Survival: A GEM Study.

Berwick M, Reiner AS, Paine S, Armstrong BK, Kricker A, Goumas C, Cust AE, Thomas NE, Groben PA, From L, Busam KJ, Orlow I, Marrett LD, Gallagher RP, Gruber SB, Anton-Culver H, Rosso S, Zanetti R, Kanetsky PA, Dwyer T, Venn AJ, Lee-Taylor J, Begg CB.

Cancer Epidemiol Biomarkers Prev. 2014 Jul 28. pii: cebp.0431.2014. [Epub ahead of print]

PMID:
25069694
[PubMed - as supplied by publisher]
3.

Blocking and randomization to improve molecular biomarker discovery.

Qin LX, Zhou Q, Bogomolniy F, Villafania L, Olvera N, Cavatore M, Satagopan JM, Begg CB, Levine DA.

Clin Cancer Res. 2014 Jul 1;20(13):3371-8. doi: 10.1158/1078-0432.CCR-13-3155. Epub 2014 May 1.

PMID:
24788100
[PubMed - in process]
4.

Breast cancer after chest radiation therapy for childhood cancer.

Moskowitz CS, Chou JF, Wolden SL, Bernstein JL, Malhotra J, Novetsky Friedman D, Mubdi NZ, Leisenring WM, Stovall M, Hammond S, Smith SA, Henderson TO, Boice JD, Hudson MM, Diller LR, Bhatia S, Kenney LB, Neglia JP, Begg CB, Robison LL, Oeffinger KC.

J Clin Oncol. 2014 Jul 20;32(21):2217-23. doi: 10.1200/JCO.2013.54.4601. Epub 2014 Apr 21.

PMID:
24752044
[PubMed - in process]
5.

Editorial transition.

Begg CB.

Clin Trials. 2014 Feb;11(1):5-6. doi: 10.1177/1740774513515551. No abstract available.

PMID:
24492146
[PubMed - in process]
6.

MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.

Berwick M, MacArthur J, Orlow I, Kanetsky P, Begg CB, Luo L, Reiner A, Sharma A, Armstrong BK, Kricker A, Cust AE, Marrett LD, Gruber SB, Anton-Culver H, Zanetti R, Rosso S, Gallagher RP, Dwyer T, Venn A, Busam K, From L, White K, Thomas NE; GEM Study Group.

Pigment Cell Melanoma Res. 2014 May;27(3):485-8. doi: 10.1111/pcmr.12215. Epub 2014 Jan 30.

PMID:
24406078
[PubMed - in process]
7.

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.

Thomas NE, Busam KJ, From L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Venn A, Kanetsky PA, Groben PA, Hao H, Orlow I, Reiner AS, Luo L, Paine S, Ollila DW, Wilcox H, Begg CB, Berwick M.

J Clin Oncol. 2013 Nov 20;31(33):4252-9. doi: 10.1200/JCO.2013.51.3002. Epub 2013 Oct 14.

PMID:
24127443
[PubMed - indexed for MEDLINE]
8.

Justifying the choice of endpoints for clinical trials.

Begg CB.

J Natl Cancer Inst. 2013 Nov 6;105(21):1594-5. doi: 10.1093/jnci/djt289. Epub 2013 Oct 9. No abstract available.

PMID:
24108810
[PubMed - indexed for MEDLINE]
9.

Testing the incremental predictive accuracy of new markers.

Begg CB, Gonen M, Seshan VE.

Clin Trials. 2013 Oct;10(5):690-2. doi: 10.1177/1740774513496490. Epub 2013 Jul 23.

PMID:
23881367
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A conceptual and methodological framework for investigating etiologic heterogeneity.

Begg CB, Zabor EC, Bernstein JL, Bernstein L, Press MF, Seshan VE.

Stat Med. 2013 Dec 20;32(29):5039-52. doi: 10.1002/sim.5902. Epub 2013 Jul 16.

PMID:
23857589
[PubMed - indexed for MEDLINE]
11.

An assessment of estimation methods for generalized linear mixed models with binary outcomes.

Capanu M, Gönen M, Begg CB.

Stat Med. 2013 Nov 20;32(26):4550-66. doi: 10.1002/sim.5866. Epub 2013 Jul 9.

PMID:
23839712
[PubMed - indexed for MEDLINE]
12.

Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report.

Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD Jr, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS, Lynch CF, Capanu M, Smith SA, Tellhed L, Teraoka SN, Begg CB, Olsen JH, Mellemkjaer L, Liang X, Diep AT, Borg A, Concannon P, Haile RW; WECARE Study Collaborative Group.

Eur J Cancer. 2013 Sep;49(14):2979-85. doi: 10.1016/j.ejca.2013.04.028. Epub 2013 May 21.

PMID:
23706288
[PubMed - indexed for MEDLINE]
13.

Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study.

Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjær L, Malone KE, Knight JA, Capanu M, Teraoka SN, Concannon P, Liang X, Figueiredo JC, Smith SA, Stovall M, Pike MC, Haile RW, Thomas DC, Begg CB, Bernstein JL.

J Clin Oncol. 2013 Feb 1;31(4):433-9. doi: 10.1200/JCO.2012.43.2013. Epub 2012 Dec 26.

PMID:
23269995
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Comparing ROC curves derived from regression models.

Seshan VE, Gönen M, Begg CB.

Stat Med. 2013 Apr 30;32(9):1483-93. doi: 10.1002/sim.5648. Epub 2012 Oct 3.

PMID:
23034816
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Detecting and exploiting etiologic heterogeneity in epidemiologic studies.

Begg CB, Zabor EC.

Am J Epidemiol. 2012 Sep 15;176(6):512-8. Epub 2012 Aug 24.

PMID:
22922440
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions.

Andrade VP, Ostrovnaya I, Seshan VE, Morrogh M, Giri D, Olvera N, De Brot M, Morrow M, Begg CB, King TA.

Breast Cancer Res. 2012 Jul 9;14(4):R103. doi: 10.1186/bcr3222.

PMID:
22776144
[PubMed - in process]
Free PMC Article
17.

Comment on "the predictive capacity of personal genome sequencing".

Begg CB, Pike MC.

Sci Transl Med. 2012 May 23;4(135):135le3; author reply 135lr3. doi: 10.1126/scitranslmed.3004162. No abstract available.

PMID:
22623736
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.

Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; GEM Study Investigators.

J Natl Cancer Inst. 2012 Jun 20;104(12):953-6. doi: 10.1093/jnci/djs221. Epub 2012 Apr 24.

PMID:
22534780
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.

Tischkowitz M, Capanu M, Sabbaghian N, Li L, Liang X, Vallée MP, Tavtigian SV, Concannon P, Foulkes WD, Bernstein L; WECARE Study Collaborative Group, Bernstein JL, Begg CB.

Hum Mutat. 2012 Apr;33(4):674-80. doi: 10.1002/humu.22022. Epub 2012 Feb 15.

PMID:
22241545
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Murali R, Goumas C, Kricker A, From L, Busam KJ, Begg CB, Dwyer T, Gruber SB, Kanetsky PA, Orlow I, Rosso S, Thomas NE, Berwick M, Scolyer RA, Armstrong BK; GEM Study Group.

Ann Surg Oncol. 2012 Mar;19(3):1024-33. doi: 10.1245/s10434-011-2058-8. Epub 2011 Sep 13. Erratum in: Ann Surg Oncol. 2013 Dec; 30 Suppl 3:S747-8.

PMID:
21913010
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk